Skip to main content
OpenTrials

Clinical trial condition

IgA Nephropathy

Explore clinical trials studying IgA Nephropathy. Study availability and eligibility vary by location and protocol.

79 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

IgA Nephropathy trial results

Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

NCT07498335

Conditions
Autoimmune Diseases, Berger Disease, Bergers Disease, +20 more
Locations
  • Hackensack Meridian Health Neptune City, New Jersey, United States
  • Cincinnati Childrens Hospital MC Cincinnati, Ohio, United States
  • University of Oklahoma Health Science Center Oklahoma City, Oklahoma, United States
  • University of Tennessee Health Science Center- Le Bonheur Research Center Memphis, Tennessee, United States
View Trial Details
Recruiting

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

NCT07541287

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Jade Clinical Site Chula Vista, California, United States
  • Jade Clinical Site Arvada, Colorado, United States
  • Jade Clinical Site Denver, Colorado, United States
  • Jade Clinical Site Orlando, Florida, United States
View Trial Details
Recruiting

Study of BHV-1400 in IgA Nephropathy

NCT07054684

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +19 more
Locations
  • Site-001 Farmington, Connecticut, United States
  • Site-003 Miami Lakes, Florida, United States
  • Site-011 Miami Lakes, Florida, United States
  • Site-013 Orlando, Florida, United States
View all 15 locations
View Trial Details
Recruiting

Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study

NCT06350630

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • CHU Gabriel Montpied Clermont-Ferrand, France
  • Hospices Civils de Lyon Lyon, France
  • AP-HM Hôpital de la Conception Marseille, France
  • APHP Hôpital Bichat Paris, France
View Trial Details
Recruiting

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

NCT06712407

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • Univ of Alabama/Birmingham Birmingham, Alabama, United States
  • Arizona Kidney Disease & Hypertension Centers (AKDHC) Glendale, Arizona, United States
  • The Medical Research Group, Inc. Fresno, California, United States
  • UCI Health-UCI Medical Center Orange, California, United States
View all 38 locations
View Trial Details
Recruiting

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

NCT06676384

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Cardiovascular Diseases, +34 more
Locations
  • Muljibhai Patel Urological Hospital Nadiād, Gujarat, India
  • JSS Medical College Mysuru, Karnataka, India
  • Kasturba Medical College, Manipal Udupi, Karnataka, India
  • KEM Hospital Mumbai, Maharashtra, India
View Trial Details
Recruiting

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

NCT06740526

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Clinical Research Site 330 Denver, Colorado, United States
  • Clinical Research Site 369 Boston, Massachusetts, United States
  • Clinical Research Site 374 Dakota Dunes, South Dakota, United States
  • Clinical Research Site 324 Houston, Texas, United States
View Trial Details

Related conditions